Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $1.1B | -- | -- | $1.48 | -- |
| 11/06/2025 | Q3 | $1.2B | $1.2B | $1.99 | $1.28 | $0.71 |
| 08/06/2025 | Q2 | $1.1B | $1.1B | $1.34 | $1.08 | $0.26 |
| 05/07/2025 | Q1 | $1.2B | $1.2B | $1.99 | $1.68 | $0.30 |
| 02/25/2025 | Q4 | $1.3B | $1.3B | $1.57 | $1.99 | -$0.42 |
| 11/07/2024 | Q3 | $1.3B | $1.3B | $3.01 | $2.07 | $0.94 |
| 08/01/2024 | Q2 | $1.3B | $1.3B | $2.15 | $2.75 | -$0.59 |
| 05/02/2024 | Q1 | $1.3B | $1.3B | $1.74 | $2.53 | -$0.79 |
| 02/27/2024 | Q4 | $1.2B | $1.1B | $3.20 | $2.82 | $0.39 |
| 11/07/2023 | Q3 | -- | $1B | $1.56 | -- | -- |
| 08/02/2023 | Q2 | -- | $660.5M | $1.72 | -- | -- |
| 05/03/2023 | Q1 | -- | $656M | $2.46 | -- | -- |
| 02/22/2023 | Q4 | -- | $814.3M | $3.29 | -- | -- |
| 10/31/2022 | Q3 | -- | $1B | $4.74 | -- | -- |
| 08/03/2022 | Q2 | -- | $1.2B | $5.48 | -- | -- |
| 05/04/2022 | Q1 | -- | $817.8M | $1.07 | -- | -- |
| 03/08/2022 | Q4 | -- | $510.5M | $2.46 | -- | -- |
| 10/28/2021 | Q3 | -- | $190M | $1.31 | -- | -- |
| 06/30/2021 | Q2 | -- | $156M | -$0.83 | -- | -- |
| 03/31/2021 | Q1 | -- | $74.2M | -$0.01 | -- | -- |
| 12/31/2020 | Q4 | -- | $62.6M | $2.89 | -- | -- |
| 09/30/2020 | Q3 | -- | $58.9M | $0.16 | -- | -- |
| 06/30/2020 | Q2 | -- | $36.2M | -$1.87 | -- | -- |
| 03/31/2020 | Q1 | -- | $60.4M | $3.80 | -- | -- |
| 12/31/2019 | Q4 | -- | $79.7M | -$0.14 | -- | -- |
| 09/30/2019 | Q3 | -- | $75.2M | $1.74 | -- | -- |
| 06/30/2019 | Q2 | -- | $85.8M | $1.99 | -- | -- |
| 03/31/2019 | Q1 | -- | $72.6M | -$0.34 | -- | -- |
| 12/31/2018 | Q4 | -- | $66.2M | $5.15 | -- | -- |
| 09/30/2018 | Q3 | -- | $74.4M | $2.10 | -- | -- |
| 06/30/2018 | Q2 | -- | $71.9M | $0.24 | -- | -- |
| 03/31/2018 | Q1 | -- | $64.2M | $0.68 | -- | -- |
| 12/31/2017 | Q4 | -- | $50.2M | -$0.28 | -- | -- |
| 09/30/2017 | Q3 | -- | $45.2M | $0.21 | -- | -- |
| 06/30/2017 | Q2 | -- | $44.1M | $4.57 | -- | -- |
| 05/09/2017 | Q1 | -- | $52.6M | -$212.73 | -- | -- |
| 02/09/2017 | Q4 | -- | $47.3M | -$152.29 | -- | -- |
| 12/14/2016 | Q3 | -- | $49.3M | -$79.23 | -- | -- |
| 08/09/2016 | Q2 | -- | $54.5M | -$111.59 | -- | -- |
| 05/10/2016 | Q1 | -- | $44.2M | -$107.12 | -- | -- |
| 02/09/2016 | Q4 | -- | $57M | -$1,312.25 | -- | -- |
Civitas Resources, Inc. reported $1.2B worth of top line sales in its most recent quarter.
Civitas Resources, Inc. announced earnings per share of $1.99 which represents a beat of analyst forecast a $1.28 per share.
Civitas Resources, Inc. reported $330M that represents $3.71 per share over the last quarter.
Civitas Resources, Inc.'s earnings are forecast to decrease from $8.46 per share to $8.82 per share next year representing a decrease of -26.86%.
Civitas Resources, Inc.'s next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.